Taipei, July 28 (CNA) Taiwan took delivery Wednesday of 504 courses of tecovirimat, an antiviral drug that can be used to treat monkeypox, the Centers for Disease Control (CDC) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in MPOX
- Taiwan reports 1st mpox deathTaiwan on Tuesday reported the nation's first death from mpox involving a Taiwanese man in his 30s, according to the Centers for Disease Control (CDC).11/07/2023 07:26 PM
- Taiwan adds China, Thailand to travel alert list amid growing mpox casesThe Taiwan Centers for Disease Control (CDC) on Tuesday raised a travel notice relating to mpox (monkeypox) for China and Thailand following surges in cases of the disease there, ...08/15/2023 10:05 PM
- Taiwan to expand vaccination to combat mpoxTaiwan's Centers for Disease Control (CDC) on Wednesday announced it would expand the mpox (monkeypox) vaccination eligibility criteria in order to include more high-risk groups ...06/28/2023 07:37 PM
Latest
- Business
U.S. dollar closes higher on Taipei forex market
03/29/2024 04:19 PM - Business
Manufacturing sector sluggish in February due to fewer working days
03/29/2024 04:11 PM - Business
Taiwan shares close up 0.73%
03/29/2024 02:03 PM - Society
Media personality Lucifer Chu gets jail time for indecent assault
03/29/2024 01:34 PM - Business
Lenovo lays off 92 employees in Taiwan: Labor ministry
03/29/2024 12:30 PM